Prevalence of methicillin-resistant Staphylococcus aureus nasal carriage in the community pediatric population

Pediatric Infectious Disease Journal

Volumn 21, Issue 10, 2002, Pages 917-921

  Nakamura, Mari M ^a   Rohling, Kasey L ^a   Shashaty, Michael ^a   Lu, Hongzhou ^a   Tang, Yi Wei ^a   Edwards, Kathryn M ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antibiotic resistance; Community acquired methicillin resistant Staphylococcus aureus; Nasal carriage

Indexed keywords

CLINDAMYCIN; COTRIMOXAZOLE; METICILLIN; OXACILLIN; PENICILLIN G; RIFAMPICIN;

ADOLESCENT; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL TRANSMISSION; CHILD; COAGULASE NEGATIVE STAPHYLOCOCCUS; COAGULASE POSITIVE STAPHYLOCOCCUS; COMMUNICABLE DISEASE; CONTROLLED STUDY; DILUTION; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEWBORN; NONHUMAN; NOSE; NOSE SMEAR; PEDIATRICS; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RISK FACTOR;

ANTI-BACTERIAL AGENTS; CARRIER STATE; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; HUMANS; INFANT; LOGISTIC MODELS; MALE; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; NASOPHARYNX; PREVALENCE; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TENNESSEE; URBAN POPULATION;

EID: 0036799604     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200210000-00006     Document Type: Article

References (26)

1. Frank AL, Marcinak JF, Mangat PD, et al. Increase in community-acquired methicillin-resistant Staphylococcus aureus in children. Clin Infect Dis 1999;29:935-6.
2. Herold BC, Immergluck LC, Maranan MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998;279: 593-8.
3. Hussain FM, Boyle-Vavra S, Bethel CD, et al. Current trends in community-acquired methicillin-resistant Staphylococcus aureus at a tertiary care pediatric facility. Pediatr Infect Dis J 2000;19:1163-6.
4. Suggs AH, Maranan MC, Boyle-Vavra S, et al. Methicillin-resistant and borderline-resistant asymptomatic Staphylococcus aureus colonization in children without identifiable risk factors. Pediatr Infect Dis J 1999;18:410-4.
5. Adcock PM, Pastor P, Medley F, et al. Methicillin-resistant Staphylococcus aureus in two child care centers. J Infect Dis 1998;178:577-80.
6. Gorak EJ, Yamada SM, Brown JD. Community-acquired methicillin-resistant Staphylococcus aureus in hospitalized adults and children without known risk factors. Clin Infect Dis 1999;29:797-800.
7. Kallen AJ, Driscoll TJ, Thorton S, et al. Increase in community-acquired Staphylococcus aureus at a naval medical center. Infect Control Hosp Epidemiol 2000;21:223-6.
8. Warshawsky B, Hussain Z, Gregson DB, et al. Hospital- and community-based surveillance of methicillin-resistant Staphylococcus aureus: previous hospitalization is the major risk factor. Infect Control Hosp Epidemiol 2000;21:724-7.
9. Alghaithy AA, Bilal NE, Gedebou M, et al. Nasal carriage and antibiotic resistance of Staphylococcus aureus isolates from hospital and non-hospital personnel in Abha, Saudi Arabia. Trans R Soc Trop Med Hyg 2000;94:504-7.
10. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus: Minnesota and North Dakota, 1997-1999. JAMA 1999;282:1123-5.
11. Shropsin B, Mathema B, Martinez J, et al. Prevalence of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in the community. J Infect Dis 2000;182:359-62.
12. Hussain FM, Boyle-Vavra S, Daum RS. Community-acquired methicillin-resistant Staphylococcus aureus colonization in healthy children attending an outpatient pediatric clinic. Pediatr Infect Dis J 2001;20:763-7.
13. Kernodle DS, Barg NL, Kaiser AB. Low-level colonization of hospitalized patients with methicillin-resistant coagulase-negative staphylococci and emergence of the organisms during surgical antimicrobial prophylaxis. Antimicrob Agents Chemother 1988;32:202-8.
14. Tang YW, Waddington MG, Smith DH, et al. Comparison of protein A gene sequencing with pulsed-field gel electrophoresis and epidemiologic data for molecular typing of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2000;38: 1347-51.
15. Tenover FC, Arbeit R, Archer G, et al. Comparison of traditional and molecular methods of typing isolates of Staphylococcus aureus. J Clin Microbiol 1994;32:407-15.
16. Ryffel C, Tesch W, Birch-Machin I, et al. Sequence comparison of mecA genes isolated from methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis. Gene 1990; 94:137-8.
17. Casewell MW. The nose: an underestimated source of Staphylococcus aureus causing wound infection. J Hosp Infect 1998;40:S3-11.
18. Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997;10:505-20.
19. Mulligan ME, Murray-Leisure KA, Ribner BS, et al. Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med 1993;94: 313-28.
20. Williams REO. Healthy carriage of Staphylococcus aureus: its prevalence and importance. Bacteriol Rev 1963;27:56-71.
21. von Eiff C, Becker K, Machka K, et al. Nasal carriage as a source of Staphylococcus aureus bacteremia. N Engl J Med 2001;344:11-16.
22. Frank AL, Marcinak JF, Mangat D, et al. Community-acquired and clindamycin-susceptible methicillin-resistant Staphylococcus aureus in children. Pediatr Infect Dis J 1999; 18:993-1000.
23. Daum RS. Community-acquired methicillin-resistant Staphylococcus aureus infections. Pediatr Infect Dis J 1998;17: 745-6.
24. Panagea S, Perry JD, Gould FK. Should clindamycin be used as treatment of patients with infection caused by erythromycin-resistant staphylococci? J Antimicrob Chemother 1999; 44:581-2.
25. Rao GG. Should clindamycin be used in treatment of patients with infections caused by erythromycin-resistant staphylococci? J Antimicrob Chemother 2000;45:715-6.
26. Fitzgerald JR, Sturdevant DE, Mackie SM, et al. Evolutionary genomics of Staphylococcus aureus: insights into the origin of methicillin-resistant strains and the toxic shock syndrome epidemic. Proc Natl Acad Sci USA 2001; 98:8821-6.